Wegovy (semaglutide) is an FDA-approved prescription medication used for chronic weight management in adults with obesity or excess weight
Importantly, most GLP-1 receptor agonists carry a boxed warning about the risk of thyroid C-cell tumors and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Weight reduction reduces apnea-hypopnea index in published literature on other interventions
A, Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R
One to two cups in the morning can be part of your constipation management strategy
While it breaks up gas bubbles to relieve pressure, it does not neutralize sulfur odors or fix the delayed gastric emptying associated with drugs like Semaglutide and Tirzepatide